More about Colgate-Palmolive (India) Limited
Fundamentals for Colgate-Palmolive (India) Limited
Regulatory Filings for Colgate-Palmolive (India) Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Colgate-Palmolive (India) Limited
Business Operations:
Sector: Consumer DefensiveIndustry: Household & Personal Products
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. The company exports its products. Colgate-Palmolive (India) Limited was incorporated in 1937 and is headquartered in Mumbai, India.
Revenue projections:
With COLPAL's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 39.199245 |
| debtToEquity | 3.791000 |
| earningsGrowth | 0.003000 |
| revenueGrowth | 0.017000 |
| grossMargins | 0.687980 |
| operatingMargins | 0.273040 |
| trailingEps | 48.840000 |
| forwardEps | 53.572460 |
COLPAL's positive gross and operating margins indicate that the company is performing profitably. These margins reflect efficient cost control and revenue generation, signaling a strong financial foundation for continued success.
COLPAL's forward EPS is greater than its trailing EPS, indicating that the company is expected to deliver higher profitability this year. This suggests that COLPAL is projected to improve its earnings, reflecting positive growth compared to last year's financial performance.
Price projections:
Price projections for COLPAL have been revised down over time, reflecting a less optimistic outlook. Analysts appear to be adjusting their expectations, signaling concerns about the company's ability to sustain its previous growth levels.
Recommendation changes over time:
The recent sell bias from analysts on COLPAL suggests investors should be cautious. However, it's a good idea to base decisions on a broader range of market indicators to gain a more complete and accurate view of the stock's potential performance in the near term.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy